David de Wied - Publications

Affiliations: 
Utrecht University, Utrecht, Netherlands 
Area:
pharmacology
Website:
http://www.dwc.knaw.nl/biografie/pmknaw/?pagetype=authorDetail&aId=PE00003843

167 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Van Ree JM, Bohus B, Csontos KM, Gispen WH, Greven HM, Nijkamp FP, Opmeer FA, de Rotte GAA, Van Wimersma Greidanus TB, Witter A, de Wied D. γ -Melanotropin and Brain Function Peptides of the Pars Intermedia. 263-276. DOI: 10.1002/9780470720646.ch15  0.766
2006 Bruins J, Kovács GL, Abbes AP, Burbach JP, van den Akker EL, Engel H, Franken AA, de Wied D. Minor disturbances in central nervous system function in familial neurohypophysial diabetes insipidus. Psychoneuroendocrinology. 31: 80-91. PMID 16125866 DOI: 10.1016/J.Psyneuen.2005.06.001  0.358
2004 Bruins J, Kovacs GL, Abbes AP, Burbach JPH, Van Den Akker ELT, Engel H, Franken AAM, De Wied D. Central nervous system functions in familial neurohypophysial diabetes insipidus Nederlands Tijdschrift Voor Klinische Chemie En Laboratoriumgeneeskunde. 29: 273-275.  0.314
1998 Bohus B, de Wied D. The vasopressin deficient Brattleboro rats: a natural knockout model used in the search for CNS effects of vasopressin. Progress in Brain Research. 119: 555-73. PMID 10074812 DOI: 10.1016/S0079-6123(08)61593-9  0.517
1998 Reijmers LG, van Ree JM, Spruijt BM, Burbach JP, De Wied D. Vasopressin metabolites: a link between vasopressin and memory? Progress in Brain Research. 119: 523-35. PMID 10074810 DOI: 10.1016/S0079-6123(08)61591-5  0.489
1997 Vawter MP, De Wied D, Van Ree JM. Vasopressin fragment, AVP-(4-8), improves long-term and short-term memory in the hole board search task. Neuropeptides. 31: 489-94. PMID 9413027  0.483
1997 Kovacs GL, De Wied D. Learning, memory and neuropeptides Endocrinology and Metabolism, Supplement. 4: 97-98.  0.368
1995 Chepkova AN, French P, De Wied D, Ontskul AH, Ramakers GM, Skrebitski VG, Gispen WH, Urban IJ. Long-lasting enhancement of synaptic excitability of CA1/subiculum neurons of the rat ventral hippocampus by vasopressin and vasopressin(4-8). Brain Research. 701: 255-66. PMID 8925289 DOI: 10.1016/0006-8993(95)01006-7  0.579
1994 Diamant M, Baars AM, Kovács GL, De Wied D. Barrel rotation induced by central arginine8-vasopressin treatment: involvement of neurohypophyseal peptide receptors. Pharmacology, Biochemistry, and Behavior. 47: 27-32. PMID 8115425 DOI: 10.1016/0091-3057(94)90107-4  0.431
1994 Kovács GL, De Wied D. Peptidergic modulation of learning and memory processes. Pharmacological Reviews. 46: 269-91. PMID 7831381  0.366
1992 Wiegant VM, Ronken E, Kovács G, De Wied D. Endorphins and schizophrenia. Progress in Brain Research. 93: 433-53. PMID 1480761  0.321
1992 Elands J, de Kloet ER, de Wied D. Neurohypophyseal hormone receptors: relation to behavior. Progress in Brain Research. 91: 459-64. PMID 1329149  0.577
1992 Kovacs GL, Baars AM, De Wied D. Antipyretic effect of central arginine8-vasopressin treatment: V1 receptors specifically involved? Life Sciences. 50: 1625-30. PMID 1315900 DOI: 10.1016/0024-3205(92)90448-X  0.403
1992 Hijman R, Jolles J, Verhoeven WMA, Van Ree JM, Elderson A, De Wied D. Desglycinamide-(Arg8)-vasopressin in five trials with memory-disturbed patients Human Psychopharmacology. 7: 7-23.  0.46
1991 Voorhuis TA, De Kloet ER, De Wied D. Ontogenetic and seasonal changes in immunoreactive vasotocin in the canary brain. Brain Research. Developmental Brain Research. 61: 23-31. PMID 1914156 DOI: 10.1016/0165-3806(91)90110-5  0.565
1991 Wolterink G, van Ree JM, van Nispen JW, de Wied D. Structural modifications of the ACTH-(4-9) analog ORG 2766 yields peptides with high biological activity. Life Sciences. 48: 155-61. PMID 1847225 DOI: 10.1016/0024-3205(91)90409-5  0.546
1991 Voorhuis TA, De Kloet ER, De Wied D. Effect of a vasotocin analog on singing behavior in the canary. Hormones and Behavior. 25: 549-59. PMID 1813380 DOI: 10.1016/0018-506X(91)90020-I  0.589
1990 Buitelaar JK, van Engeland H, van Ree JM, de Wied D. Behavioral effects of Org 2766, a synthetic analog of the adrenocorticotrophic hormone (4-9), in 14 outpatient autistic children. Journal of Autism and Developmental Disorders. 20: 467-78. PMID 2177746 DOI: 10.1007/BF02216053  0.652
1989 Kovács GL, Liu B, Burbach JP, Van Ree JM, De Wied D. N alpha-acetyl-[Arg8]vasopressin antagonizes the behavioral effect of [Cyt6]vasopressin-(5-9), but not of vasopressin. European Journal of Pharmacology. 161: 27-35. PMID 2721547 DOI: 10.1016/0014-2999(89)90176-3  0.645
1989 de Wied D, van Ree JM. Neuropeptides: animal behaviour and human psychopathology. European Archives of Psychiatry and Neurological Sciences. 238: 323-31. PMID 2670577 DOI: 10.1007/BF00449813  0.523
1989 Ten Haaf JA, Van Wimersma Greidanus TB, De Wied D. The effect of different types of anaesthesia on rat eye plexus and peripheral plasma vasopressin levels Neuroscience Research Communications. 4: 175-181.  0.568
1988 Voorhuis TA, Kiss JZ, de Kloet ER, de Wied D. Testosterone-sensitive vasotocin-immunoreactive cells and fibers in the canary brain. Brain Research. 442: 139-46. PMID 3359249 DOI: 10.1016/0006-8993(88)91441-2  0.559
1988 Voorhuis TA, de Kloet ER, de Wied D. The distribution and plasticity of [3H]vasopressin-labelled specific binding sites in the canary brain. Brain Research. 457: 148-53. PMID 2971421 DOI: 10.1016/0006-8993(88)90067-4  0.568
1988 Lebouille JL, Burbach JP, De Kloet ER, Wiegant VM, Sweep CG, De Wied D. Leu-Phe cleaving endopeptidase activity, gamma-endorphin, and beta-endorphin in the rat pituitary gland and brain. Effect of adrenalectomy and corticosterone substitution. Neuroendocrinology. 47: 7-12. PMID 2448702  0.609
1987 Kiss JZ, Voorhuis TA, van Eekelen JA, de Kloet ER, de Wied D. Organization of vasotocin-immunoreactive cells and fibers in the canary brain. The Journal of Comparative Neurology. 263: 347-64. PMID 3667983 DOI: 10.1002/cne.902630304  0.556
1987 de Wied D, Gaffori O, Burbach JP, Kovács GL, van Ree JM. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. The Journal of Pharmacology and Experimental Therapeutics. 241: 268-74. PMID 3572787  0.632
1987 Laczi F, László FA, Kovács GL, Telegdy G, Szász A, Szilárd J, van Ree JM, de Wied D. Differential effect of desglycinamide9-(Arg8)-vasopressin on cognitive functions of diabetes insipidus and alcoholic patients. Acta Endocrinologica. 115: 392-8. PMID 3303787 DOI: 10.1530/Acta.0.1150392  0.619
1987 De Wied D, Van Ree JM. Non-opiate effects of neuropeptides derived from beta-endorphin. Polish Journal of Pharmacology and Pharmacy. 39: 623-32. PMID 2976164  0.533
1987 De Wied D, De Kloet ER. Pro-opiomelanocortin (POMC) as homeostatic control system. Annals of the New York Academy of Sciences. 512: 328-37. PMID 2831780  0.528
1987 Dekker A, Gispen WH, de Wied D. Axonal regeneration, growth factors and neuropeptides. Life Sciences. 41: 1667-78. PMID 2443782  0.466
1987 van Ree JM, Verhoeven WM, de Wied D. Animal and clinical research on neuropeptides and schizophrenia. Progress in Brain Research. 72: 249-67. PMID 2441432 DOI: 10.1016/S0079-6123(08)60213-7  0.598
1986 Drago F, Van Ree JM, De Wied D. Desenkephalin-gamma-endorphin restores the impaired sensitivity of hypophysectomized rats to small doses of apomorphine. European Journal of Pharmacology. 128: 205-12. PMID 3792442 DOI: 10.1016/0014-2999(86)90767-3  0.549
1986 Kovács GL, Veldhuis HD, Versteeg DH, De Wied D. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures. Brain Research. 371: 17-24. PMID 3708341 DOI: 10.1016/0006-8993(86)90805-X  0.486
1986 Gispen WH, Isaacson RL, Spruijt BM, de Wied D. Melanocortins, neural plasticity and aging. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 415-26. PMID 3025925 DOI: 10.1016/0278-5846(86)90015-1  0.543
1986 Fekete M, Van Ree JM, De Wied D. The ACTH-(4-9) analog ORG 2766 and desglycinamide9-(Arg8)-vasopressin reverse the retrograde amnesia induced by disrupting circadian rhythms in rats. Peptides. 7: 563-8. PMID 3020524  0.56
1986 Drago F, Bohus B, Bitetti R, Scapagnini U, van Ree JM, de Wied D. Intracerebroventricular injection of anti-prolactin serum suppresses excessive grooming of pituitary homografted rats. Behavioral and Neural Biology. 46: 99-105. PMID 3015122 DOI: 10.1016/S0163-1047(86)90938-6  0.672
1986 ten Haaf JA, van Wimersma Greidanus TB, Maigret C, De Wied D. Effect of the opioid peptide beta-endorphin on the in vivo release of vasopressin in rats under various conditions. Neuroendocrinology. 44: 102-7. PMID 2946974  0.613
1986 van Ree JM, Verhoeven WM, Claas FH, de Wied D. Antipsychotic action of gamma-type endorphins: animal and human studies. Progress in Brain Research. 65: 221-35. PMID 2431435 DOI: 10.1016/S0079-6123(08)60653-6  0.622
1986 Bovenberg RA, Burbach JP, Wiegant VM, Veeneman GH, van Boom JH, Baas PD, Jansz HS, de Wied D. gamma-Endorphin and schizophrenia: amino acid composition of gamma-endorphin and nucleotide sequence of gamma-endorphin cDNA from pituitary glands of schizophrenic patients. Brain Research. 376: 29-37. PMID 2424570 DOI: 10.1016/0006-8993(86)90896-6  0.548
1986 Claas FH, van Ree JM, Verhoeven WM, van der Poel JJ, Verduyn W, de Wied D, van Rood JJ. The interaction between gamma-type endorphins and HLA class I antigens. Human Immunology. 15: 347-56. PMID 2422143 DOI: 10.1016/0198-8859(86)90011-X  0.61
1985 Fekete M, van Ree JM, Niesink RJ, de Wied D. Disrupting circadian rhythms in rats induces retrograde amnesia. Physiology & Behavior. 34: 883-7. PMID 4059376 DOI: 10.1016/0031-9384(85)90008-3  0.516
1985 van Wimersma Greidanus TB, Jolles J, De Wied D. Hypothalamic neuropeptides and memory. Acta Neurochirurgica. 75: 99-105. PMID 3993453 DOI: 10.1007/BF01406329  0.751
1985 Van Ree JM, Hijman R, Jolles J, De Wied D. Vasopressin and related peptides: animal and human studies. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 551-9. PMID 3911283 DOI: 10.1016/0278-5846(85)90016-8  0.708
1985 de Kloet ER, Voorhuis TA, Burbach JP, de Wied D. Autoradiographic localization of binding sites for the arginine-vasopressin (VP) metabolite, VP4-9, in rat brain. Neuroscience Letters. 56: 7-11. PMID 2989735 DOI: 10.1016/0304-3940(85)90432-X  0.608
1985 van Ree JM, de Wied D. Behavioral effects of non-opioid fragments of beta-endorphin. Progress in Clinical and Biological Research. 192: 277-84. PMID 2934744  0.53
1985 Van Ree JM, Verhoeven WM, De Wied D. Gamma-type endorphins: neurolepticum-like and antipsychotic action. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 561-7. PMID 2418467 DOI: 10.1016/0278-5846(85)90017-X  0.656
1985 de Rotte AA, van Wimersma Greidanus TB, van de Buuse M, Andringa-Bakker EA, de Wied D. The effect of gamma-type endorphins on alpha-MSH release in the rat. Life Sciences. 37: 263-71. PMID 2409428 DOI: 10.1016/0024-3205(85)90652-6  0.588
1984 Laczi F, Gaffori O, Fekete M, de Kloet ER, de Wied D. Levels of arginine-vasopressin in cerebrospinal fluid during passive avoidance behavior in rats. Life Sciences. 34: 2385-91. PMID 6727572 DOI: 10.1016/0024-3205(84)90426-0  0.613
1984 Burbach JP, De Hoop MJ, Schmale H, Richter D, De Kloet ER, Ten Haaf JA, De Wied D. Differential responses to osmotic stress of vasopressin-neurophysin mRNA in hypothalamic nuclei. Neuroendocrinology. 39: 582-4. PMID 6514139 DOI: 10.1159/000124040  0.582
1984 de Wied D, Gaffori O, van Ree JM, de Jong W. Central target for the behavioural effects of vasopressin neuropeptides. Nature. 308: 276-8. PMID 6322010  0.534
1984 Verhoeven WM, van Ree JM, Westenberg HG, Krul JM, Brouwer GJ, Thijssen JH, de Wied D, van Praag HM, Ceulemans DL, Kahn RS. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia. Psychiatry Research. 11: 329-46. PMID 6204351 DOI: 10.1016/0165-1781(84)90006-4  0.726
1984 van Ree JM, Verhoeven WM, Brouwer GJ, de Wied D. Ceruletide resembles antipsychotics in rats and schizophrenic patients. Preliminary report. Neuropsychobiology. 12: 4-8. PMID 6151145 DOI: 10.1159/000118101  0.681
1984 van Heuven-Nolsen D, De Kloet ER, De Wied D, Versteeg DH. Microinjection of vasopressin and two related peptides into the amygdala: enhancing effect on local dopamine neurotransmission. Brain Research. 293: 191-5. PMID 6142753 DOI: 10.1016/0006-8993(84)91470-7  0.598
1984 De Wied D, Gaffori O, Van Ree JM, De Jong W. Vasopressin antagonists block peripheral as well as central vasopressin receptors. Pharmacology, Biochemistry, and Behavior. 21: 393-400. PMID 6093152  0.515
1983 De Kloet ER, Drago F, Mezey E, Bohus B, De Wied D. Pituitary stalk section transiently impairs the acquisition of shuttle box avoidance behavior. Physiology & Behavior. 30: 499-502. PMID 6878451 DOI: 10.1016/0031-9384(83)90211-1  0.693
1983 Laczi F, Gaffori O, de Kloet ER, de Wied D. Differential responses in immunoreactive arginine-vasopressin content of microdissected brain regions during passive avoidance behavior. Brain Research. 260: 342-6. PMID 6831206  0.624
1983 Laczi F, van Ree JM, Wagner A, Valkusz Z, Járdánházy T, Kovács GL, Telegdy G, Szilárd J, László FA, de Wied D. Effects of desglycinamide-arginine-vasopressin (DG-AVP) on memory processes in diabetes insipidus patients and non-diabetic subjects. Acta Endocrinologica. 102: 205-12. PMID 6829260 DOI: 10.1530/Acta.0.1020205  0.652
1983 Burbach JP, Bohus B, Kovács GL, Van Nispen JW, Greven HM, De Wied D. Oxytocin is a precursor of potent behaviourally active neuropeptides. European Journal of Pharmacology. 94: 125-31. PMID 6653655 DOI: 10.1016/0014-2999(83)90449-1  0.599
1983 Laczi F, Gaffori O, De Kloet ER, De Wied D. Arginine-vasopressin content of hippocampus and amygdala during passive avoidance behavior in rats. Brain Research. 280: 309-15. PMID 6652491 DOI: 10.1016/0006-8993(83)90060-4  0.611
1983 Kovács GL, De Wied D. Hormonally active arginine-vasopressin suppresses endotoxin-induced fever in rats: lack of effect of oxytocin and a behaviorally active vasopressin fragment. Neuroendocrinology. 37: 258-61. PMID 6355890  0.505
1983 Burbach JP, Kovács GL, de Wied D, van Nispen JW, Greven HM. A major metabolite of arginine vasopressin in the brain is a highly potent neuropeptide. Science (New York, N.Y.). 221: 1310-2. PMID 6351252  0.488
1983 van Wimersma Greidanus TB, van Ree JM, de Wied D. Vasopressin and memory. Pharmacology & Therapeutics. 20: 437-58. PMID 6351117 DOI: 10.1016/0163-7258(83)90036-0  0.651
1983 van Wimersma Greidanus TB, Bohus B, Kovács GL, Versteeg DH, Burbach JP, De Wied D. Sites of behavioral and neurochemical action of ACTH-like peptides and neurohypophyseal hormones. Neuroscience and Biobehavioral Reviews. 7: 453-63. PMID 6322066 DOI: 10.1016/0149-7634(83)90023-4  0.76
1983 Bijlsma WA, Schotman P, Jennekens FG, Gispen WH, De Wied D. The enhanced recovery of sensorimotor function in rats is related to the melanotropic moiety of ACTH/MSH neuropeptides. European Journal of Pharmacology. 92: 231-6. PMID 6313395 DOI: 10.1016/0014-2999(83)90291-1  0.611
1983 Fekete M, Drago F, Van Ree JM, Bohus B, Wiegant VM, De Wied D. Naltrexone-sensitive behavioral actions of the ACTH 4-9 analog (Org 2766). Life Sciences. 32: 2193-204. PMID 6302425 DOI: 10.1016/0024-3205(83)90417-4  0.655
1983 Drago F, Bohus B, Gispen WH, Scapagnini U, De Wied D. Prolactin-enhanced grooming behavior: interaction with ACTH. Brain Research. 263: 277-82. PMID 6301648 DOI: 10.1016/0006-8993(83)90320-7  0.701
1983 Fekete M, Bohus B, de Wied D. Comparative effects of ACTH-related peptides on acquisition of shuttle-box avoidance behavior of hypophysectomized rats. Neuroendocrinology. 36: 112-8. PMID 6300716 DOI: 10.1159/000123446  0.56
1983 Kovàcs GL, Bohus B, De Wied D. Effects of beta-endorphin and its fragments on inhibitory avoidance behavior in rats. Psychoneuroendocrinology. 8: 411-9. PMID 6201940 DOI: 10.1016/0306-4530(83)90020-3  0.61
1983 Van Ree JM, Gaffori O, De Wied D. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents. European Journal of Pharmacology. 93: 63-78. PMID 6138272 DOI: 10.1016/0014-2999(83)90031-6  0.556
1983 Serra G, Van Ree JM, de Wied D. Influence of classical and atypical neuroleptics on apomorphine-induced behavioural changes and on extinction of a conditioned avoidance response. The Journal of Pharmacy and Pharmacology. 35: 255-7. PMID 6133940  0.441
1982 Drago F, Bohus B, Van Ree JM, Scapagnini U, De Wied D. Behavioral responses of long-term hyperprolactinaemic rats. European Journal of Pharmacology. 79: 323-7. PMID 7201402 DOI: 10.1016/0014-2999(82)90641-0  0.537
1982 Hagan JJ, Bohus B, de Wied D. Post-training vasopressin injections may facilitate or delay shuttle-box avoidance extinction. Behavioral and Neural Biology. 36: 211-28. PMID 7183316 DOI: 10.1016/S0163-1047(82)90843-3  0.426
1982 Kovács GL, Telegdy G, De Wied D. Selective attenuation of passive avoidance behaviour by microinjection of beta-LPH62-77 and beta-LPH66-77 into the nucleus accumbens in rats. Neuropharmacology. 21: 451-4. PMID 7110535 DOI: 10.1016/0028-3908(82)90030-2  0.584
1982 Verhoeven WM, van Ree JM, Heezius-van Bentum A, de Wied D, van Praag HM. Antipsychotic properties of Des-enkephalin-gamma-endorphin in treatment of schizophrenic patients. Archives of General Psychiatry. 39: 648-54. PMID 7092498 DOI: 10.1001/ARCHPSYC.1982.04290060010003  0.515
1982 Fekete M, Bohus B, Van Wolfswinkel L, Van Ree JM, De Wied D. Comparative effects of the ACTH 4-9 analogue (ORG 2766), ACTH 4-10 and [D-Phe7] ACTH 4-10 on medial septal self-stimulation behaviour in rats. Neuropharmacology. 21: 909-16. PMID 6292772 DOI: 10.1016/0028-3908(82)90083-1  0.494
1982 de Jongh BM, Verhoeven WM, van Ree JM, de Wied D, van Rood JJ. Hla, and the response to treatment with gamma-type endorphins in schizophrenia. Journal of Immunogenetics. 9: 381-8. PMID 6186747 DOI: 10.1111/j.1744-313X.1982.tb00999.x  0.613
1982 van Ree JM, Verhoeven WM, de Wied D, van Praag HM. The use of the synthetic peptides gamma-type endorphins in mentally ill patients. Annals of the New York Academy of Sciences. 398: 478-95. PMID 6186176 DOI: 10.1111/j.1749-6632.1982.tb39519.x  0.493
1982 Nijkamp FP, van Ree JM, Nijssen JG, Versluis M, de Wied D. Opposite interactions between alpha- and beta-endorphin fragments with dopamine mediated responses on the rat rectum in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology. 321: 213-7. PMID 6185856 DOI: 10.1007/BF00505488  0.502
1982 Van Ree JM, Innemee H, Louwerens JW, Kahn RS, De Wied D. Non-opiate beta-endorphin fragments and dopamine--I. The neuroleptic-like gamma-endorphin fragments interfere with the behavioural effects elicited by small doses of apomorphine. Neuropharmacology. 21: 1095-101. PMID 6184639 DOI: 10.1016/0028-3908(82)90166-6  0.369
1982 De Wied D, Jolles J. Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. Physiological Reviews. 62: 976-1059. PMID 6124016  0.583
1982 Versteeg DH, Kovács GL, Bohus B, de Kloet ER, de Wied D. Effect of des-Tyr1-gamma-endorphin and des-Tyr1-alpha-endorphin on alpha-MPT-induced catecholamine disappearance in rat brain nuclei: a dose--response study. Brain Research. 231: 343-51. PMID 6120024 DOI: 10.1016/0006-8993(82)90371-7  0.731
1981 Verhoeven WM, van Ree JM, de Wied D, van Praag HM. gamma-Type endorphins and schizophrenia. Archives of General Psychiatry. 38: 1182-3. PMID 7294969 DOI: 10.1001/ARCHPSYC.1981.01780350116012  0.466
1981 Drago F, Van Ree JM, Bohus B, de Wied D. Endogenous hyperprolactinaemia enhances amphetamine- and apomorphine-induced stereotypy. European Journal of Pharmacology. 72: 249-53. PMID 7195817 DOI: 10.1016/0014-2999(81)90281-8  0.481
1981 Verhoeven WM, Westenberg HG, Gerritsen TW, van Praag HM, Thijssen JH, Schwarz F, van Ree JM, de Wied D. (Des-tyrosine1)-gamma-endorphin in schizophrenia: clinical, biochemical, and hormonal aspects. Psychiatry Research. 5: 293-309. PMID 7034028 DOI: 10.1016/0165-1781(81)90076-7  0.665
1981 van Wimersma Greidanus TB, van Ree JM, Goedemans HJ, van Dam AF, Andringa-Bakker EA, de Wied D. Effects of beta-endorphin fragments on plasma levels of vasopressin. Life Sciences. 29: 783-8. PMID 6272048 DOI: 10.1016/0024-3205(81)90033-3  0.546
1981 Burbach JP, De Kloet ER, Schotman P, De Wied D. Proteolytic conversion of beta-endorphin by brain synaptic membranes. Characterization of generated beta-endorphin fragments and proposed metabolic pathway. The Journal of Biological Chemistry. 256: 12463-9. PMID 6271786  0.572
1981 van Ree JM, Bohus B, Csontos KM, Gispen WH, Greven HM, Nijkamp FP, Opmeer FA, de Rotte GA, van Wimersma Greidanus TB, Witter A, de Wied D. Gamma-melanotropin and brain function. Ciba Foundation Symposium. 81: 263-76. PMID 6268381  0.777
1981 van Ree JM, Bohus B, Csontos KM, Gispen WH, Greven HM, Nijkamp FP, Opmeer FA, de Rotte GA, van Wimersma Greidanus TB, Witter A, de Wied D. Behavioral profile of gamma-MSH: relationship with ACTH and beta-endorphin action. Life Sciences. 28: 2875-8. PMID 6267399 DOI: 10.1016/0024-3205(81)90104-1  0.775
1981 van Dijk AM, van Wimersma Greidanus TB, Burbach JP, de Kloet ER, de Wied D. Brain adrenocorticotrophin after adrenalectomy and sham-operation of rats. The Journal of Endocrinology. 88: 243-53. PMID 6259267  0.747
1981 Van Ree JM, Verhoeven WM, Van Praag HM, De Wied D. Neuroleptic-like and antipsychotic effects of gamma-type endorphins. Modern Problems of Pharmacopsychiatry. 17: 266-78. PMID 6173744 DOI: 10.1159/000402422  0.495
1981 de Rotte AA, van Wimersma Greidanus TB, van Ree JM, Andringa-Bakker EA, de Wied D. The influence of beta-LPH fragments on alpha-MSH release: the involvement of a dopaminergic system. Life Sciences. 29: 825-32. PMID 6170858 DOI: 10.1016/0024-3205(81)90039-4  0.547
1981 Kovács GL, Bohus B, De Wied D. Retention of passive avoidance behavior in rats following alpha- and gamma-endorphin administration: effects of post-learning treatments. Neuroscience Letters. 22: 79-82. PMID 6164024 DOI: 10.1016/0304-3940(81)90289-5  0.603
1981 Drago F, Bohus B, De Wied D. Interaction between vasopressin and oxytocin in the modulation of passive avoidance retention of the rat Neuroscience Letters. 24: S260.  0.503
1980 Drago F, Bohus B, Scapagnini U, de Wied D. Sexual dimorphism in passive avoidance behavior of rats: relation to body weight, age, shock intensity and retention interval. Physiology & Behavior. 24: 1161-4. PMID 7413797 DOI: 10.1016/0031-9384(80)90064-5  0.476
1980 Burbach JP, Loeber JG, Verhoef J, Wiegant VM, de Kloet ER, de Wied D. Selective conversion of beta-endorphin into peptides related to gamma- and alpha-endorphin. Nature. 283: 96-7. PMID 7350533 DOI: 10.1038/283096A0  0.604
1980 van Wimersma Greidanus TB, de Wied D. Physiological significance of neurohypophyseal hormones in memory processes. Acta Psychiatrica Belgica. 80: 721-7. PMID 7195141  0.628
1980 Burbach JP, Schotman P, Verhoef J, de Kloet ER, de Wied D. Conversion of des-tyrosine-gamma-endorphin by brain synaptic membrane associated peptidases: identification of generated peptide fragments. Biochemical and Biophysical Research Communications. 97: 995-1004. PMID 7008797  0.586
1980 Burbach JP, De Kloet ER, De Wied D. Oxytocin biotransformation in the rat limbic brain: characterization of peptidase activities and significance in the formation of oxytocin fragments. Brain Research. 202: 401-14. PMID 7002262  0.603
1980 Rees HD, Verhoef J, Witter A, Gispen WH, de Wied D. Autoradiographic studies with a behaviorally potent 3H-ACTH4--9 analog in the brain after intraventricular injection in rats. Brain Research Bulletin. 5: 509-14. PMID 6253028  0.614
1980 Nyakas C, Bohus B, de Wied D. Effects of ACTH4--10 on self-stimulation behavior in the rat. Physiology & Behavior. 24: 759-64. PMID 6248912 DOI: 10.1016/0031-9384(80)90409-6  0.512
1980 Gispen WH, Ormond D, ten Haaf J, De Wied D. Modulation of ACTH-induced grooming by [Des-Tyr1]-gamma-endorphin and haloperidol. European Journal of Pharmacology. 63: 203-7. PMID 6247168  0.603
1980 Verhoef J, Loeber JG, Burbach JP, Gispen WH, Witter A, de Wied D. Alpha-endorphin, gamma-endorphin and their des-tyrosine fragments in rat pituitary and brain tissue. Life Sciences. 26: 851-9. PMID 6154859 DOI: 10.1016/0024-3205(80)90347-1  0.588
1980 Gispen WH, de Wied D. ACTH as neuromodulator: behavioral and neurochemical aspects. Progress in Clinical and Biological Research. 39: 251-63. PMID 6105672  0.552
1980 Hagan JJ, Bohus B, De Wied D. Post training lysine vasopressin (LVP) may facilitate or delay shuttle box avoidance extinction Neuroscience Letters. 19: S206.  0.407
1979 de Loos WS, Bohus B, de Jong W, de Wied D. Reduction of heart-rate reactions to emotional stress by ovarian hormones in rats [proceedings]. The Journal of Endocrinology. 81: 138P-139P. PMID 572411  0.453
1979 Versteeg DH, De Kloet ER, De Wied D. Effects of alpha-endorphin, beta-endorphin and (des-tyr1)-gamma-endorphin on alpha-MPT-induced cateholamine disappearance in discrete regions of the rat brain. Brain Research. 179: 85-92. PMID 509235 DOI: 10.1016/0006-8993(79)90492-X  0.611
1979 Kovács GL, Bohus B, Versteeg DH, de Kloet ER, de Wied D. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures. Brain Research. 175: 303-14. PMID 487159 DOI: 10.1016/0006-8993(79)91009-6  0.759
1979 Dorsa DM, van Ree JM, De Wied D. Effects of [Des-Tyr 1]-gamma-endorphin and alpha-endorphin on substantia nigra self-stimulation. Pharmacology, Biochemistry, and Behavior. 10: 899-905. PMID 482311 DOI: 10.1016/0091-3057(79)90065-0  0.485
1979 Dorsa DM, de Kloet ER, Mezey E, de Wied D. Pituitary-brain transport of neurotensin: functional significance of retrograde transport. Endocrinology. 104: 1663-6. PMID 446387 DOI: 10.1210/endo-104-6-1663  0.717
1979 Verhoeven WM, van Praag HM, van Ree JM, de Wied D. Improvement of schizophrenic patients treated with [des-Tyr1]-gamma-endorphin (DTgammaE). Archives of General Psychiatry. 36: 294-8. PMID 369471 DOI: 10.1001/ARCHPSYC.1979.01780030060005  0.524
1979 Loeber JG, van Wimersma Greidanus TB, de Wied D. Evidence for the existence of highly specific neuropeptides which affect the maintenance of avoidance behaviour [proceedings]. The Journal of Endocrinology. 80: 9P. PMID 220372  0.534
1979 Versteeg DH, De Kloet ER, Greidanus TV, De Wied D. Vasopressin modulates the activity of catecholamine containing neurons in specific brain regions. Neuroscience Letters. 11: 69-73. PMID 219400 DOI: 10.1016/0304-3940(79)90058-2  0.615
1979 Burbach JP, Loeber JG, Verhoef J, de Kloet ER, van Ree JM, de Wied D. Schizophrenia and degradation of endorphins in cerebrospinal fluid. Lancet. 2: 480-1. PMID 89549  0.531
1979 Burbach JP, Loeber JG, Verhoef J, de Kloet ER, de Wied D. Biotransformation of endorphins by a synaptosomal plasma membrane preparation of rat brain and by human serum. Biochemical and Biophysical Research Communications. 86: 1296-303. PMID 35164  0.601
1978 de Wied D, Bohus B. The modulation of memory processes by vasotocin, the evolutionarily oldest neurosecretory principle. Progress in Brain Research. 48: 327-36. PMID 746161 DOI: 10.1016/S0079-6123(08)61032-8  0.443
1978 Kovács GL, de Wied D. Effects of amphetamine and haloperidol on avoidance behavior and exploratory activity. European Journal of Pharmacology. 53: 103-7. PMID 738353 DOI: 10.1016/0014-2999(78)90272-8  0.453
1978 Bohus B, Kovács GL, de Wied D. Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes. Brain Research. 157: 414-7. PMID 719533 DOI: 10.1016/0006-8993(78)90052-5  0.569
1978 Bohus B, Urban I, van Wimersma Greidanus TB, de Wied D. Opposite effects of oxytocin and vasopressin on avoidance behaviour and hippocampal theta rhythm in the rat. Neuropharmacology. 17: 239-47. PMID 652136 DOI: 10.1016/0028-3908(78)90107-7  0.698
1978 Versteeg DH, Tanaka M, De Kloet ER, Van Ree JM, De Wied D. Prolyl-leucyl-glycinamide (PLG); regional effects on alpha-MPT-induced catecholamine disappearance in rat brain. Brain Research. 143: 561-6. PMID 647380  0.625
1978 Dogterom J, van Wimersma Greidanus TB, De Wied D. Vasopressin in cerebrospinal fluid and plasma of man, dog, and rat. The American Journal of Physiology. 234: E463-7. PMID 645897  0.589
1978 van Ree JM, Slangen JL, de Wied D. Intravenous self-administration of drugs in rats. The Journal of Pharmacology and Experimental Therapeutics. 204: 547-57. PMID 633066  0.554
1978 van Ree JM, Bohus B, Versteeg DH, de Wied D. Neurohypophyseal principles and memory processes. Biochemical Pharmacology. 27: 1793-800. PMID 361045 DOI: 10.1016/0006-2952(78)90021-7  0.441
1978 Mezey E, Palkovits M, de Kloet ER, Verhoef J, de Wied D. Evidence for pituitary-brain transport of a behaviorally potent ACTH analog. Life Sciences. 22: 831-8. PMID 205745  0.603
1978 de Wied D, Bohus B, van Ree JM, Urban I. Behavioral and electrophysiological effects of peptides related to lipotropin (beta-LPH). The Journal of Pharmacology and Experimental Therapeutics. 204: 570-80. PMID 204766  0.543
1978 de Wied D, Bohus B, van Ree JM, Kovács GL, Greven HM. Neuroleptic-like activity of [des-Tyr1]-gamma-endorphin in rats. Lancet. 1: 1046. PMID 76966 DOI: 10.1016/S0140-6736(78)90773-0  0.613
1978 De Wied D, Kovács GL, Bohus B, Van Ree JM, Greven HM. Neuroleptic activity of the neuropeptide beta-LPH62-77 ([Des-Tyr1]gamma-endorphin; DT gamma E). European Journal of Pharmacology. 49: 427-36. PMID 27374 DOI: 10.1016/0014-2999(78)90317-5  0.634
1977 Tanaka M, de Kloet ER, de Wied D, Versteeg DH. Arginine8-vasopressin affects catecholamine metabolism in specific brain nuclei. Life Sciences. 20: 1799-808. PMID 875620  0.584
1977 Kruse H, Van Wimersma Greidanus TB, De Wied D. Barrel rotation induced by vasopressin and related peptides in rats. Pharmacology, Biochemistry, and Behavior. 7: 311-3. PMID 563083  0.615
1977 Gispen WH, Reith ME, Schotman P, Wiegant VM, Zwiers H, de Wied D. CNS and ACTH-like peptides: neurochemical response and interaction with opiates. Advances in Biochemical Psychopharmacology. 17: 61-80. PMID 200081  0.68
1977 Wiegant VM, Gispen WH, Terenius L, de Wied D. ACTH-like peptides and morphine: interaction at the level of the CNS. Psychoneuroendocrinology. 2: 63-70. PMID 198834  0.549
1977 Van Wimersma Greidanus TB, Rees LH, Scott AP, Lowry PJ, De Wied D. ACTH release during passive avoidance behavior. Brain Research Bulletin. 2: 101-4. PMID 195676 DOI: 10.1016/0361-9230(77)90005-3  0.568
1977 Verhoef J, Witter A, De Wied D. Specific uptake of a behaviorally potent [3H]ACTH4-9 analog in the septal area after intraventricular injection in rats. Brain Research. 131: 117-28. PMID 195674 DOI: 10.1016/0006-8993(77)90032-4  0.327
1977 Gispen WH, van Ree JM, de Wied D. Lipotropin and the central nervous system. International Review of Neurobiology. 20: 209-50. PMID 22510  0.493
1977 Reith M, Schotman P, Gispen W, de Wied D. Pituitary peptides as modulators of neural functioning Trends in Biochemical Sciences. 2: 56-58. DOI: 10.1016/0968-0004(77)90095-0  0.539
1976 Dogterom J, van Wimersma Greidanus TB, De Wied D. Histamine as an extremely potent releaser of vasopressin in the rat. Experientia. 32: 659-60. PMID 1278325 DOI: 10.1007/BF01990220  0.603
1976 De Wied D, Gispen WH. Impaired development of tolerance to morphine analgesia in rats with hereditary diabetes insipidus. Psychopharmacologia. 46: 27-9. PMID 1257364 DOI: 10.1007/BF00421545  0.585
1976 Van Wimersma Greidanus TB, De Wied D. Modulation of passive-avoidance behavior of rats by intracerebroventricular administration of antivasopressin serum. Behavioral Biology. 18: 325-33. PMID 1035099 DOI: 10.1016/S0091-6773(76)92279-3  0.609
1976 de Wied D, van Wimersma Greidanus TB, Bohus B, Urban I, Gispen WH. Vasopressin and memory consolidation. Progress in Brain Research. 45: 181-94. PMID 1013337 DOI: 10.1016/S0079-6123(08)60990-5  0.73
1976 Gispen WH, Wiegant VM, Bradbury AF, Hulme EC, Smyth DG, Snell CR, de Wied D. Induction of excessive grooming in the rat by fragments of lipotropin. Nature. 264: 794-5. PMID 189197 DOI: 10.1038/264794A0  0.628
1976 Gispen WH, Buitelaar J, Wiegant VM, Terenius L, De Wied D. Interaction between ACTH fragments, brain opiate receptors and morphine-induced analgesia. European Journal of Pharmacology. 39: 393-7. PMID 185067  0.587
1975 van Wimersma Greidanus TB, Bohus B, de Wied D. The role of vasopressin in memory processes. Progress in Brain Research. 42: 135-41. PMID 1197719 DOI: 10.1016/S0079-6123(08)63654-7  0.648
1975 Gispen WH, Krivoy WA, de Wied D, Zimmermann E. Effect of rifampicin on development of tolerance to analgesic actions. Life Sciences. 17: 247-51. PMID 1160497  0.504
1975 Bohus B, Greidanus TV, DE Wied D. Behavioral and endocrine responses of rats with hereditary hypothalamic diabetes insipidus (Brattleboro strain). Physiology & Behavior. 14: 609-15. PMID 1135324 DOI: 10.1016/0031-9384(75)90189-4  0.486
1975 van Wimersma Greidanus TB, Bohus B, de Wied D. Proceedings: The role of vasopressin in memory consolidation. The Journal of Endocrinology. 64: 30P-31P. PMID 1133519  0.647
1975 Terenius L, Gispen WH, De Wied D. ACTH-like peptides and opiate receptors in the rat brain: structure-activity studies. European Journal of Pharmacology. 33: 395-9. PMID 241656 DOI: 10.1016/0014-2999(75)90185-5  0.601
1975 van Wimersma Greidanus TB, Lowry PJ, Scott AP, Rees LH, De Wied D. The effects of dogfish MSH's and of corticotrophin-like intermediate lobe peptides (CLIP's) on avoidance behavior in rats. Hormones and Behavior. 6: 319-27. PMID 177349 DOI: 10.1016/0018-506X(75)90002-1  0.613
1975 Gispen WH, Wiegant VM, Greven HM, de Wied D. The induction of excessive grooming in the rat by intraventricular application of peptides derived from ACTH: structure-activity studies. Life Sciences. 17: 645-52. PMID 171535  0.589
1975 Gispen WH, Van Wimersma Greidanus TB, Waters-Ezrin C, Zimmermann E, Krivoy WA, De Wied D. Influence of peptides on reduced response of rats to electric footshock after acute administration of morphine. European Journal of Pharmacology. 33: 99-105. PMID 170120 DOI: 10.1016/0014-2999(75)90143-0  0.719
1974 de Wied D, Van Wimersma Greidanus TB, Bohus B. The rat supraoptic-neurohypophyseal system and behavior: role of vasopressin in memory processes. Problã¨Mes Actuels D'Endocrinologie Et De Nutrition. 323-8. PMID 4471148  0.701
1974 de Wied D, Bohus B, van Wimersma Greidanus TB. The hypothalamo-neurohypophyseal system and the preservation of conditioned avoidance behavior in rats. Progress in Brain Research. 41: 417-28. PMID 4445512  0.691
1974 van Wimersma Greidanus TB, Bohus B, de Wied D. The parafasicular area as the site of action of ACTH analogs on avoidance behavior. Progress in Brain Research. 41: 429-32. PMID 4374723  0.66
1974 v Wimerdma Greidanus TB, Bohus B, de Wied D. Differential localization of the influence of lysine vasopressin and of ACTH 4-10 on avoidance behavior: a study in rats bearing lesions in the parafascicular nuclei. Neuroendocrinology. 14: 280-8. PMID 4368018  0.514
1973 Bohus B, Gispen WH, De Wied D. Effect of lysine vasopressin and ACTH 4-10 on conditioned avoidance behavior of hypophysectomized rats. Neuroendocrinology. 11: 137-43. PMID 4349360 DOI: 10.1159/000122126  0.698
1972 Bohus B, Ader R, de Wied D. Effects of vasopressin on active and passive avoidance behavior. Hormones and Behavior. 3: 191-7. PMID 4680509 DOI: 10.1016/0018-506X(72)90031-1  0.481
1972 Schotman P, Gispen WH, Jansz HS, De Wied D. Effects of ACTH analogues on macromolecule metabolism in the brain stem of hypophysectomized rats. Brain Research. 46: 349-62. PMID 4344078 DOI: 10.1016/0006-8993(72)90025-X  0.711
1972 Versteeg DH, Gispen WH, Schotmann P, Witter A, de Wied D. Hypophysectomy and rat brain metabolism: effects of synthetic ACTH analogs. Advances in Biochemical Psychopharmacology. 6: 219-39. PMID 4341334  0.595
1971 Gispen WH, de Wied D, Schotman P, Jansz HS. Brain stem polysomes and avoidance performance of hypophysectomized rats subjected to peptide treatment. Brain Research. 31: 341-51. PMID 4328057 DOI: 10.1016/0006-8993(71)90187-9  0.715
1970 Gispen WH, de Wied D, Schotman P, Jansz HS. On the relationship between the deficient performance of hypophysectomized rats in shuttle-box conditioning and the RNA metabolism in their brain stem. Brain Research. 24: 551. PMID 5494550  0.69
1970 Gispen WH, de Wied D, Schotman P, Jansz HS. Effects of hypophysectomy on RNA metabolism in rat brain stem. Journal of Neurochemistry. 17: 751-61. PMID 4987663 DOI: 10.1111/J.1471-4159.1970.Tb03345.X  0.68
1970 Gispen WH, v Wimersma Greidanus TB, de Wied D. Effects of hypophysectomy and ACTH 1-10 on responsiveness to electric shock in rats. Physiology & Behavior. 5: 143-6. PMID 4337772  0.572
1967 Bohus B, de Wied D. Avoidance and escape behavior following medial thalamic lesions in rats. Journal of Comparative and Physiological Psychology. 64: 26-9. PMID 6064430 DOI: 10.1037/h0024793  0.502
1967 Bohus B, de Wied D. Facilitatory and inhibitory influences on the pituitary-adrenal system: a study with chlorpromazine. Rassegna Di Neurologia Vegetativa. 21: 71-83. PMID 4308389  0.457
1967 de Wied D, Bohus B, Ernst AM, de Jong W, Nieuwehuizen W, Pieper EE, Yasumura S. Several aspects of the influence of vasopressin on pituitary-adrenal activity. Proceedings of the Royal Society of Medicine. 60: 907-8. PMID 4293796  0.456
1966 De Wied D, Bohus B. Long term and short term effects on retention of a conditioned avoidance response in rats by treatment with long acting pitressin and α-MSH [48] Nature. 212: 1484-1486. DOI: 10.1038/2121484a0  0.448
1957 BOUMAN PR, GAARENSTROOM JH, SMELIK PG, DE WIED D. Hypothalamic lesions and ACTH secretion in rats. Acta Physiologica Et Pharmacologica Neerlandica. 6: 368-78. PMID 13487383  0.654
1954 GAARENSTROOM JH, GROEN A, DE WIED D. The relation between the ACTH-content of the blood and the urinary excretion of 17-ketosteroids. Acta Endocrinologica. 17: 89-99. PMID 13227819  0.595
1953 DE WIED D, GAARENSTROOM JH. The relation between ACTH and intermedine. Acta Endocrinologica. 12: 361-70. PMID 13057523  0.609
Show low-probability matches.